Invasive fungal infection (IFI) is a rare but serious complication of traumatic injury. The purpose of this article is to review the epidemiology, natural history, mycology, risk factors, diagnosis, treatment, and outcomes associated with post-traumatic IFI in military and civilian populations.
The epidemiology of post-traumatic IFI is poorly characterized, but incidence appears to be rising. Patients often suffer from severe injuries and require extensive medical interventions. Fungi belonging to the order Mucorales are responsible for most post-traumatic IFI in both civilian and military populations. Risk factors differ between these cohorts but include specific injury patterns and comorbidities.
Diagnosis of post-traumatic IFI typically follows positive laboratory results in the appropriate clinical context. The gold standard of treatment is surgical debridement in addition to systemic antifungal therapy. Patients with post-traumatic IFI may be at greater risk of amputation, delays in wound healing, hospital complications, and death as compared to trauma patients who do not develop IFI.
Compound N014-0001 |
|||
| T131360-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Compound N014-0001 |
|||
Compound N014-0001 |
|||
| T131360-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Compound N014-0001 |
|||
Compound N099-0001 |
|||
| T131154-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Compound N099-0001 |
|||
Compound N099-0001 |
|||
| T131154-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Compound N099-0001 |
|||
Compound N099-0001 |
|||
| T131154-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Compound N099-0001 |
|||
Compound N099-0001 |
|||
| T131154-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Compound N099-0001 |
|||
Compound N099-0001 |
|||
| T131154-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Compound N099-0001 |
|||
Compound N094-0001 |
|||
| T131162-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Compound N094-0001 |
|||
Compound N094-0001 |
|||
| T131162-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Compound N094-0001 |
|||
Compound N094-0001 |
|||
| T131162-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Compound N094-0001 |
|||
Compound N094-0001 |
|||
| T131162-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Compound N094-0001 |
|||
Compound N094-0001 |
|||
| T131162-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Compound N094-0001 |
|||
Compound N075-0001 |
|||
| T131175-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Compound N075-0001 |
|||
Compound N075-0001 |
|||
| T131175-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Compound N075-0001 |
|||
Compound N075-0001 |
|||
| T131175-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Compound N075-0001 |
|||
Compound N075-0001 |
|||
| T131175-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Compound N075-0001 |
|||
Compound N075-0001 |
|||
| T131175-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Compound N075-0001 |
|||
Compound N034-0001 |
|||
| T131298-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Compound N034-0001 |
|||
Compound N034-0001 |
|||
| T131298-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Compound N034-0001 |
|||
Compound N034-0001 |
|||
| T131298-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Compound N034-0001 |
|||
Compound N034-0001 |
|||
| T131298-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Compound N034-0001 |
|||
Compound N034-0001 |
|||
| T131298-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Compound N034-0001 |
|||
Compound N032-0001 |
|||
| T131302-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Compound N032-0001 |
|||
Compound N032-0001 |
|||
| T131302-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Compound N032-0001 |
|||
Compound N032-0001 |
|||
| T131302-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Compound N032-0001 |
|||
Compound N032-0001 |
|||
| T131302-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Compound N032-0001 |
|||
Compound N032-0001 |
|||
| T131302-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Compound N032-0001 |
|||
Compound N029-0001 |
|||
| T131303-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Compound N029-0001 |
|||
Compound N029-0001 |
|||
| T131303-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Compound N029-0001 |
|||
Compound N029-0001 |
|||
| T131303-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Compound N029-0001 |
|||
Compound N029-0001 |
|||
| T131303-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Compound N029-0001 |
|||
Compound N029-0001 |
|||
| T131303-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Compound N029-0001 |
|||
More research is needed to understand the factors surrounding the development and management of post-traumatic IFI to reduce the significant morbidity and mortality associated with this disease.